<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress.com" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>egf &amp;laquo; WordPress.com Tag Feed</title>
	<link>http://en.wordpress.com/tag/egf/</link>
	<description>Feed of posts on WordPress.com tagged "egf"</description>
	<pubDate>Tue, 01 Dec 2009 12:22:01 +0000</pubDate>

	<generator>http://en.wordpress.com/tags/</generator>
	<language>en</language>

<item>
<title><![CDATA[Fortele politiei militare internationale ale UE (EGF) POT reprima nesupunerea publica]]></title>
<link>http://mucenicul.wordpress.com/2009/09/19/fortele-politiei-militare-internationale-ale-ue-egf-pot-reprima-nesupunerea-publica/</link>
<pubDate>Sat, 19 Sep 2009 18:32:47 +0000</pubDate>
<dc:creator>mucenicul</dc:creator>
<guid>http://mucenicul.wordpress.com/2009/09/19/fortele-politiei-militare-internationale-ale-ue-egf-pot-reprima-nesupunerea-publica/</guid>
<description><![CDATA[&#8221; Nu vă faceţi griji de trupele ONU franceze, trupele ONU spaniole, trupele ONU române sau ori]]></description>
<content:encoded><![CDATA[&#8221; Nu vă faceţi griji de trupele ONU franceze, trupele ONU spaniole, trupele ONU române sau ori]]></content:encoded>
</item>
<item>
<title><![CDATA[The European Gendarmerie Force (EGF) - die neue Super-Gestapo]]></title>
<link>http://kehraus.wordpress.com/2009/09/19/the-european-gendarmerie-force-egf-die-neue-superpolizei/</link>
<pubDate>Sat, 19 Sep 2009 08:23:50 +0000</pubDate>
<dc:creator>kehraus</dc:creator>
<guid>http://kehraus.wordpress.com/2009/09/19/the-european-gendarmerie-force-egf-die-neue-superpolizei/</guid>
<description><![CDATA[European Gendarmerie Force (EGF) &#8211; schon mal gehört? Nein? Dann gewöhnen sie sich besse mal da]]></description>
<content:encoded><![CDATA[European Gendarmerie Force (EGF) &#8211; schon mal gehört? Nein? Dann gewöhnen sie sich besse mal da]]></content:encoded>
</item>
<item>
<title><![CDATA[EU’s International Military Police Force (EGF) Can Squash Public Disobedience *]]></title>
<link>http://dprogram.net/2009/09/18/eu%e2%80%99s-international-military-police-force-egf-can-squash-public-disobedience/</link>
<pubDate>Fri, 18 Sep 2009 21:22:00 +0000</pubDate>
<dc:creator>sakerfa</dc:creator>
<guid>http://dprogram.net/2009/09/18/eu%e2%80%99s-international-military-police-force-egf-can-squash-public-disobedience/</guid>
<description><![CDATA[Don’t worry about French UN troops, Spanish UN troops, Romanian UN troops or any other UN troops bei]]></description>
<content:encoded><![CDATA[Don’t worry about French UN troops, Spanish UN troops, Romanian UN troops or any other UN troops bei]]></content:encoded>
</item>
<item>
<title><![CDATA[Assigné en justice pour avoir analysé des raisins !]]></title>
<link>http://sosbiodiversite.wordpress.com/2009/06/04/assigne-en-justice-pour-avoir-analyse-des-raisins/</link>
<pubDate>Thu, 04 Jun 2009 21:51:00 +0000</pubDate>
<dc:creator>Kalisse</dc:creator>
<guid>http://sosbiodiversite.wordpress.com/2009/06/04/assigne-en-justice-pour-avoir-analyse-des-raisins/</guid>
<description><![CDATA[Agissons ensemble pour soutenir cette association&#8230; Signez l&#8217;Appel à soutien d&#8217;EGF,]]></description>
<content:encoded><![CDATA[Agissons ensemble pour soutenir cette association&#8230; Signez l&#8217;Appel à soutien d&#8217;EGF,]]></content:encoded>
</item>
<item>
<title><![CDATA[3-7 mai 2009 EP täiskogu istung]]></title>
<link>http://katrinsaks.wordpress.com/2009/05/11/3-7-mai-2009-ep-taiskogu-istung/</link>
<pubDate>Mon, 11 May 2009 20:13:46 +0000</pubDate>
<dc:creator>katrinsaks</dc:creator>
<guid>http://katrinsaks.wordpress.com/2009/05/11/3-7-mai-2009-ep-taiskogu-istung/</guid>
<description><![CDATA[Juunis aset leidnud praeguse parlamendikoosseisu viimasel täiskogu istungil enne valimisi toimus mit]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p>Juunis aset leidnud praeguse parlamendikoosseisu viimasel täiskogu istungil enne valimisi toimus mitu olulist hääletust. Muuhulgas olid hääletusel telekommunikatsioonipakett ning varjupaigataotlejate vastuvõtu miinimumnõuded. Vähem kajastust leidis hääletus Euroopa Globaliseerumisega Kohanemise Fondi (EGF) üle, mis aga praegustes tingumustes on pea sama oluline kui teised mainitud eelnõud. Kirjutan sellest lühidalt all. Hääletuste vahepeal kohtusin Euroopa Komisjoni tarbijkaitsevolinik Meglena Kunevaga, et arutada Eesti tarbijakaitse mureküsimusi.</p>
<p>Volinik rõhutas kohtumisel, et uutes liikmesriikides tuleb rohkem tähelepanu pöörata tarbija teadlikkusele, sest tarbija, kes teab oma õiguseid, saab oma õiguste eest ka paremini seista. Kindlasti tuleks rohkem ressursse  suunata tarbijakaitsesse läbi toetuse Tarbijakaitseametile, aga ka kolmanda sektori organisatsioonidele. Eestis on küllalt palju südikaid tarbijakaitsjaid, kellele tuleks anda vahendid, et nad oma tööd paremini teha saaks.</p>
<p>Rääkisime ka SMS laenudest ning sellega seotud probleemidest Eestis. Volinik juhtis tähelepanu SMS-laenudega seotud probleemidele ka teistes Euroopa Liidu liikmesriikides ning avaldas lootust, et Rootsi kaasusest saaks hea eeskuju teistelegi liikmesriikidele.</p>
<p>Oluliseks vestlusteemaks kujunes kollektiivhagide problemaatika. Vastavalt Euroopa Komisjoni poolt tellitud uuringule oleksid nii Eesti kui teiste Euroopa Liidu liikmesriikide tarbijad valmis oma õiguste eest seisma, võttes ette kohtutee, kui seda oleks võimalik teha koos teistega. Hetkel kaalub Euroopa Komisjon võimalusi kollektiivse kahjuhüvitamise mehhanismi sisse viimiseks piiriüleste tarbijaõiguse rikkumiste puhul nähes sellel kasu liikmesriikides, kus see juba eksisteerib. Mitmed Euroopa Liidu riigid on juba kasutusele võtnud kollektiivmenetluse nii et miks mitte kaaluda seda ka Eesti kontekstis?</p>
<p>Tarbijakaitse volinik on jõulise tegutsemisega tarbijakaitse poliitikale Brüsselis oluliselt hoogu juurde andnud. Kuneva pingutused on olnud suureks abiks tarbija teadlikkuse tõstmisel ning tarbijate olukorra üldisel parandamisel Euroopa Liidu liikmesriikides. Tuleb loota et Komisjon jätkab samas vaimus ka edaspidi.</p>
<p>Ülal mainitud uue <strong>EGF määruse</strong> kohaselt, mille parlament hääletusel kinnitas, saavad liikmesriigid taotleda abi, kui korraga jääb ettevõttes töötuks 500 või rohkem inimest. Fondi eesmärgiks on rahastada iga-aastaselt 500 miljoni euro ulatuses liikmesriikide meetmeid, mis aitavad inimesi tagasi tööturule. Euroopa Liidu Nõukogu ja Euroopa Parlamendi kokkuleppest tulenevalt on liikmesriikidel võimalik raha taotleda juhul, kui töö on kaotanud 500 inimest, kes on seotud ühe ettevõtte või ühe sektoriga. Euroopa Liit rahastab 65 protsenti projektidest, 35 protsenti osas peavad liikmesriigid ise vahendid leidma. Uue määrusega laiendadakse ajutiselt 2010. aasta lõpuni EGFi reguleerimisala nii, et see hõlmaks ka ülemaailmsest finants- ja majanduskriisist põhjustatud koondamisi.</p>
<p>Isegi kui Eestis pole Euroopa mõttes suurettevõtteid, siis Eestis on korraga ka mitmesaja inimese töötuksjäämine väga suure mõjuga, näiteks kasvõi Kreenholmi või Elcoteq&#8217;i puhul. Kui varem rakendus EGF juhul, kui tööta jäänud inimeste arv ulatus tuhande inimeseni siis uue määrusega on see 500, mis on vägagi teretulnud. Erandjuhtudel võib taotluse esitada ka siis, kui see kriteerium ei ole täidetud.</p>
<p>Euroopa Liidu abiga on võimalik suunata raha tööturu olukorra leevendamiseks – erinevateks koolitusteks ja abiks tööotsimisel. Eestis on aga üllatavalt vähe kasutanud Euroopa Sotsiaalfondi raha. Euroopa raha kasutamine nii Euroopa Sotsiaalfondist kui EGFist peab kindlasti muutuma prioriteedidiks, et leevedada töötust Eestis.</p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[AV-412]]></title>
<link>http://kinasepro.wordpress.com/2009/04/13/av-412-2/</link>
<pubDate>Tue, 14 Apr 2009 02:35:31 +0000</pubDate>
<dc:creator>kinasepro</dc:creator>
<guid>http://kinasepro.wordpress.com/2009/04/13/av-412-2/</guid>
<description><![CDATA[Aveo&#8217;s Ph1 irreversible  Erbb inhibitor: via Mitsubishi]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p>Aveo&#8217;s <a href="http://www.clinicaltrials.gov/ct2/results?term=av-412">Ph1</a> irreversible  Erbb inhibitor:</p>
<p style="text-align:center;"><img class="aligncenter size-full wp-image-935" title="av-412" src="http://kinasepro.wordpress.com/files/2009/04/av-412.jpg" alt="C=CC(NC1=CC2=C(N=CN=C2C=C1C#CC(C)(C)N3CCN(CC3)C)NC4=CC=C(C(Cl)=C4)F)=O" width="500" height="214" /></p>
<p>via <a href="http://www.aveopharma.com/content/media-news/news-detail.jsp/q/news-id/16">Mitsubishi</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Europa 002 De Europese gendarmerie.]]></title>
<link>http://worldthechanges.wordpress.com/2009/04/06/europa-002-de-europese-gendarmerie/</link>
<pubDate>Mon, 06 Apr 2009 17:18:57 +0000</pubDate>
<dc:creator>worldthechanges</dc:creator>
<guid>http://worldthechanges.wordpress.com/2009/04/06/europa-002-de-europese-gendarmerie/</guid>
<description><![CDATA[‘k Had er nog nooit van gehoord. Eurogendfor! Totdat ik surfte en terecht kwam bij het “verdrag” dat]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p align="center"><a href="http://worldthechanges.files.wordpress.com/2009/04/politiek-0002701-eurogendfor-de-europese-gendarmerie-2007.jpg"><img style="border-bottom:0;border-left:0;border-top:0;border-right:0;" src="http://worldthechanges.files.wordpress.com/2009/04/politiek-0002701-eurogendfor-de-europese-gendarmerie-2007-thumb.jpg?w=354&#038;h=179" border="0" alt="politiek 0002701 eurogendfor de europese gendarmerie 2007" width="354" height="179" /></a></p>
<p align="center">‘k Had er nog nooit van gehoord.</p>
<p align="center"><a href="http://www.eurogendfor.org/"><strong><span style="color:#ff0000;">Eurogendfor</span></strong></a>!</p>
<p align="center">Totdat ik surfte en terecht kwam bij het “<a href="http://www.minbuza.nl/verdragen/nl/nieuwsberichten,ondertekening-EURGENDFOR.html"><strong><span style="color:#ff0000;">verdrag</span></strong></a>” dat het ministerie van Buitenlandse Zaken op 18-10-2007 schijnt te hebben ondertekend.</p>
<p align="center">Een combinatie van zo’n 800 man sterke politiemacht met militaire bevoegdheden ( te zijner tijd uitbreidbaar naar zo’n 2.300 man sterk ) die in een tijdspanne van 30 dagen volkomen paraat in een samenwerkingsverband tussen de landen Frankrijk, Italië, Portugal, Nederland en Spanje aan elkaar “uitgewisseld” kunnen worden.</p>
<p align="center">Het hoofdkwartier schijnt in Vicence ( Italië ) te zitten.</p>
<p align="center">Als reden om deze militaire politiemacht op te richten, werd gesteld:</p>
<p align="center">“<em>Tijdens recente internationale <strong>crisisbeheersings- en vredesoperaties</strong> is gebleken dat er in <strong>instabiele situaties</strong>, naast de noodzaak voor militaire vredeshandhavingseenheden, een bijzondere behoefte bestaat aan <strong>robuuste politie-eenheden die zelfstandig inzetbaar zijn</strong>. Tegen deze achtergond hebben de deelnemende landen, die allen beschikken over een dergelijk politiekorps met militaire status, besloten de EGF op te richten.</em>”</p>
<p align="center"><strong>Crisisbeheersing</strong> – <strong>Instabiele situaties</strong> – <strong>Zelfstandig inzetbaar</strong> – Een <strong>beetje ondoorzichtig</strong> allemaal!</p>
<p align="center">Maar vooral <strong>erg achterbaks en gluiperig</strong> tot stand gekomen!</p>
<p align="center"><a href="http://worldthechanges.files.wordpress.com/2009/04/politiek-0002702-eurogendfor-frankrijk-italie-nederland-portugal-roemenie-spanje.jpg"><img style="border-bottom:0;border-left:0;border-top:0;border-right:0;" src="http://worldthechanges.files.wordpress.com/2009/04/politiek-0002702-eurogendfor-frankrijk-italie-nederland-portugal-roemenie-spanje-thumb.jpg?w=354&#038;h=179" border="0" alt="politiek 0002702 eurogendfor frankrijk italie nederland portugal roemenie spanje" width="354" height="179" /></a></p>
<p align="center"><strong>De </strong><a href="http://www.eurogendfor.org/"><strong><span style="color:#ff0000;">European Gendarmerie Force</span></strong></a><strong>!</strong></p>
<p align="center">Europa lijkt hiermee weer een eind op weg een militaire macht ( lees fascistische staat ) te worden.</p>
<p align="center">Gezien de <strong>onduidelijke taakomschrijving</strong> van dit machtsapparaat met termen als “<strong>crisisbeheersing</strong>”, en “<strong>instabiele situaties</strong>”, mijn vraag of het reëel is te veronderstellen dat deze in actie kan komen wanneer er sprake is van een <strong>bevolkingsopstand</strong>, of zou een <strong>massieve volksdemonstratie</strong> al genoeg zijn?</p>
<p align="center">In ieder geval zou deze “interventie macht” van zo’n 800 man sterk, binnen 30 dagen inzetbaar moeten zijn.</p>
<p align="center">Wat is het nut van een 2e politiemacht, als we kijken naar <a href="http://www.europol.europa.eu/"><strong><span style="color:#ff0000;">EUROPOL</span></strong></a>.</p>
<p align="center">Wat is het nut van een 2<sup>e</sup> leger, als we kijken naar de <a href="http://www.navo-nederland.be/"><strong><span style="color:#ff0000;">NAVO</span></strong></a>.</p>
<p align="center">Waarom de oprichting van de <strong>EGF</strong> ( <strong>E</strong>uropean <strong>G</strong>endarmerie <strong>F</strong>orce )?</p>
<p align="center">Een politie / militaire macht die in 1<sup>e</sup> instantie ter beschikking staat van de EU zelf.</p>
<p align="center">Op de website van EuroGendFor zelf, is te zien welke media aandacht hebben geschonken aan de oprichting!</p>
<p align="center">De <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=1"><strong><span style="color:#ff0000;">Franse media</span></strong></a> scheen hierover geschreven te hebben in 2005, 2006 en 2007</p>
<p align="center">De <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=2"><strong><span style="color:#ff0000;">Italiaanse media</span></strong></a> scheen hierover geschreven te hebben in 2004, 2005 en 2006.</p>
<p align="center">De <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=4"><strong><span style="color:#ff0000;">Portugese media</span></strong></a> scheen hierover geschreven te hebben in 2006.</p>
<p align="center">De <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=5"><strong><span style="color:#ff0000;">Spaanse media</span></strong></a> scheen hierover geschreven te hebben in 2005 en 2006.</p>
<p align="center">De <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=6"><strong><span style="color:#ff0000;">Britse media</span></strong></a> ( die notabene niet eens mee doet ) scheen hierover geschreven te hebben in 2005, 2006 en 2007.</p>
<p align="center">Maar waar blijven de berichten van de <a href="http://www.eurogendfor.org/PressReview.aspx?langcd=3"><strong><span style="color:#ff0000;">Nederlandse media</span></strong></a>?!?</p>
<p align="center">Zo wordt maar weer eens bevestigd hoe <strong>ACHTERBAKS en GLUIPERIG</strong> Nederlandse politici en media zijn!</p>
<p align="center"><strong>Relevante informatie:</strong></p>
<p align="center">Wat moet de Europese Unie nou met een EuroGendFor?</p>
<p align="center"><a href="http://englandexpects.blogspot.com/2007/10/what-would-eu-do-with-one-of-these.html"><strong><span style="color:#ff0000;">18-10-2007</span></strong></a> England Expects website: What would the EU do with one of these?</p>
<p align="center"><a href="http://worldthechanges.files.wordpress.com/2009/04/europa-000203-vladimir-bukovsky-en-de-eussr.jpg"><img style="border-bottom:0;border-left:0;border-top:0;border-right:0;" src="http://worldthechanges.files.wordpress.com/2009/04/europa-000203-vladimir-bukovsky-en-de-eussr-thumb.jpg?w=354&#038;h=179" border="0" alt="europa 000203 vladimir bukovsky en de eussr" width="354" height="179" /></a></p>
<p align="center">De EUSSR is een monster dat zo snel mogelijk moet worden vernietigd, <a href="http://www.brusselsjournal.com/system/files?file=bukovsky-interview.mp3"><strong><span style="color:#ff0000;">aldus Vladimir Bukovsky</span></strong></a> ( .mp3 gespreksopname ) een Russische dissident die in Groot-Brittannië woont!</p>
<p align="center">Het scheppen van een nieuwe generatie mensen genaamd “Europeanen” ( zoals dat destijds is gebeurd met de Russen en de Amerikanen ) luidt een nieuw machtsblok in!</p>
<p align="center">Zo zou Denemarken tot 2x toe TEGEN het “Verdrag van Maastricht” hebben gestemd en Ierland TEGEN het “Verdrag van Nice”, beiden zijn uiteindelijk gezwicht voor politieke druk ( chantage )!</p>
<p align="center"><a href="http://www.brusselsjournal.com/node/865"><strong><span style="color:#ff0000;">27-02-2006</span></strong></a> Former Soviet dissident warns for EU dictatorship!</p>
<p align="center">Wie het Europarlement controleert, controleert de hele Europese Unie</p>
<p align="center"><a href="http://video.google.com/videoplay?docid=3664960863576873594&#38;hl=en-GB"><strong><span style="color:#ff0000;">Google Video</span></strong></a> &#8211; Common Purpose Government Infiltrators!</p>
<p align="center"><a href="http://www.eutruth.org.uk/"><strong><span style="color:#ff0000;">EUtruth</span></strong></a> &#8211; Do you know the truth about the EU?</p>
<p align="center"><a href="http://www.eu2007.pt/NR/rdonlyres/6B75C05A-DA13-4F0D-BEE5-787BB0B45231/0/DAPEGFFinalrevisedtreatycleantext27SEP07.pdf"><strong><span style="color:#ff0000;">Officieel document</span></strong></a> over het verdrag aangaande de oprichting van de Europeaanse Gendarmerie!</p>
<p align="center">De reden waarom het communisme niet werkte, en het Europees socialisme net zo veel kans van slagen heeft als het communisme, zeer uitvoerig verteld, met de invoering van een gemeenzaam betaalmiddel, de herpositionering van militaire troepen over de wereld en de groei van NATO, het ontbreken van religieuze termen in het verdrag, zodra de Europese Unie een voldongen feit is, zal een nieuwe oorlog uitbreken, aldus Vladimir Bukovsky!</p>
<p align="center"><a href="http://www.unitypublishing.com/Government/EUSSR-US2.htm"><strong><span style="color:#ff0000;">Soviet roots</span></strong></a> of Socialist European Union – Richard Salbato!</p>
<p align="center"><strong>Nog even iets over het ontstaan van een dictatuur, iets waarin Europa uiteindelijk zal veranderen.</strong></p>
<p align="center"><strong>De 3 stappen waarop een dictatuur zijn oorsprong vind:</strong></p>
<p align="center">Maak van elke burger een individualist – doordat iedereen de eigen belangen voor die van anderen stelt is de kans op nauwe samenwerking en dus het samenscholen tegen het systeem zowat geminimaliseerd.</p>
<p align="center">Plaats elk individu in een hokje en plak er een label op – hierdoor kun je het systeem bemannen met voorstanders van het systeem en tegenstanders gemakkelijker in de gaten houden.</p>
<p align="center">Snoer tegenstanders de mond – ontneem tegenstanders van het systeem alle vormen van communicatie ( gsm en internet ) opdat zij zich niet kunnen verenigen tegen het systeem.</p>
<p align="center">Zo claimt <a href="http://gatesofvienna.blogspot.com/2007/10/italys-plan-to-shut-down-internet.html#readfurther"><strong><span style="color:#ff0000;">Gates of Viënna</span></strong></a> in een artikel van 19-10-2007, dat Italië plannen heeft om het internet aan banden te leggen.</p>
<p align="center">“At the siege of Vienna in 1683 Islam seemed poised to overrun Christian Europe.</p>
<p align="center">We are in a new phase of a very old war.”</p>
<p align="center">Eenzelfde claim van <a href="http://www.beppegrillo.it/eng/2007/10/the_leviprodi_law_and_the_end.html"><strong><span style="color:#ff0000;">BeppeGrillo</span></strong></a> betreffende Italiaanse internetbeperking vanuit de <a href="http://www.beppegrillo.it/immagini/DDL_editoria_030807.pdf"><strong><span style="color:#ff0000;">Levi-Prodi law</span></strong></a><strong> </strong>( helaas een Italiaanse .pdf file ), waarbij bloggers zich moeten laten registreren, moeten zijn aangesloten bij een uitgever en een speciale belasting moeten betalen.</p>
<p align="center">Wanneer deze wet wordt aangenomen moet iedereen die een blogsite exploiteerd, deze laten registreren bij het ROC ( Registro degli Operatori della Comunicazione ).</p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[AEE-788]]></title>
<link>http://kinasepro.wordpress.com/2009/03/16/aee-788/</link>
<pubDate>Mon, 16 Mar 2009 05:44:07 +0000</pubDate>
<dc:creator>kinasepro</dc:creator>
<guid>http://kinasepro.wordpress.com/2009/03/16/aee-788/</guid>
<description><![CDATA[aka: NVP-AEE788 is Novartis&#8217; VEGF / EGF &#8216;Nib (&amp;src, &amp;flt, etc.) in Ph1 for the l]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p>aka: NVP-AEE788 is Novartis&#8217; VEGF / EGF &#8216;Nib (&#38;src, &#38;flt, etc.) in <a href="http://clinicaltrials.gov/ct2/results?term=AEE-788">Ph1</a> for the last 6 years&#8230; and unceremoniously <a href="http://www.novartisoncology.com/research-innovation/pipeline.jsp?usertrack.filter_applied=true&#38;NovaId=3350119544727832788">off the pipeline</a>.<a href="http://clinicaltrials.gov/ct2/results?term=AEE-788"><br />
</a></p>
<p style="text-align:center;"><img class="aligncenter size-full wp-image-786" title="aee-788" src="http://kinasepro.wordpress.com/files/2009/03/aee-788.jpg" alt="C[C@H](C1=CC=CC=C1)NC2=C3C(NC(C4=CC=C(C=C4)CN5CCN(CC5)CC)=C3)=NC=N2" width="350" height="247" /></p>
<p style="text-align:center;"><a href="http://cancerres.aacrjournals.org/cgi/content/abstract/64/14/4931">Cancer Res</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Euroopa globaliseerumisfond toetab töö kaotanuid]]></title>
<link>http://katrinsaks.wordpress.com/2009/02/11/euroopa-globaliseerumisfond-toetab-too-kaotanuid/</link>
<pubDate>Wed, 11 Feb 2009 20:33:54 +0000</pubDate>
<dc:creator>katrinsaks</dc:creator>
<guid>http://katrinsaks.wordpress.com/2009/02/11/euroopa-globaliseerumisfond-toetab-too-kaotanuid/</guid>
<description><![CDATA[Pingutused selleks, et võidelda globaliseerumise negatiivsete mõjudega, nagu tööstuse ja töökohtade ]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><!--StartFragment--></p>
<p class="MsoNormal"><span lang="EN-GB">Pingutused selleks, et v</span><span lang="ET">õidelda globaliseerumise negatiivsete mõjudega, nagu tööstuse ja töökohtade kolimine Euroopast (ja ka Eestist) parematele jahimaadele, on asendunud pingutustega selleks, et võidelda majandussurutisega.</span></p>
<p class="MsoNormal"><span lang="ET">Selge märk sellest on Euroopa Komisjoni majandussurutisest välja aitamise pakett, mis estati eelmise aasta lõpus. <span> </span>Üheks osaks paketi osaks on kaks aastat tagasi algatatud Globaliseerumisega Kohanemise Euroopa Fondi (EGF) ümber kohandamine, et aidata kaasa majandussurutisest tulenevate raskustega võitlemisel. </span></p>
<p class="MsoNormal"><span lang="ET">Globaliseerumisfond asutati 2007. aastal eesmärgiga toetada ettevõtteid, mis on mõjutatud üleilmastumisest tekkinud struktuursetest muutustest majanduses. Sellest fondist on taotlenud raha töötute ümberkoolitamiseks ja muudeks tööturgu puudutavateks meetmeteks liikmesriigid, kes on kaotanud töökohti sellistes sektorites nagu näiteks tekstiilitööstus Itaalias ja autotööstus Hispaanias. Aga samuti on EL abi taotluse esitanud ka Leedu, et saada hüvitist Alytaus Textile tekstiiliettevõttes koondamise tõttu töö kaotatanud ca 1000 inimesele.</span></p>
<p class="MsoNormal"><span lang="ET">Sotsiaalministeeriumi andmetel<span>  </span>ei ole Eesti<span>  </span>EGFist raha taotlenud, kuigi põhjust ehk oleks olnud. Võtame kasvõi meie Kreenholmi. Põhjendadakse seda sellega, et struktuurifondidest ja peamiselt just Sotsiaalfondist saadav toetus on piisav. Samuti on põhjendatud EGF vähest kasutamist taotlemise keerukusega. </span></p>
<p class="MsoNormal"><span lang="ET">Mingil määral on see ka põhjendatud. Kuigi EGFist loodeti suurt abi, on taotlusi olnud 500 miljoni euro suurusele fondile vaid 10-15% ulatuses. Ja põhjendatakse seda just avalduste esitamise keerukusega. Aga ka sellega, et EL kaasfinantseering ulatub 50 protsendini, samas kui näiteks Sotsiaalfondi meetmete EL kaasfinatseering on üldjuhul 75-85 protsenti. Samuti soosib fond suuri liikmesriike, kui vaadata kasvõi Eestis toimunud koondamisi, mis harva ulatuvad üle 1000 (mis on fondi aktiveerumise piirmäär). Kreenholmis eelmisel aastal avalikustatud koondamised küündivad ka vaid veidi üle 900. Samas mitme aasta arvestuses on neid ju tuhandeid.</span></p>
<p class="MsoNormal"><span lang="ET">Tingituna sellest, et EGF<span>  </span>raha kasutamine ei olnud optimaalne, sooviti esialgu üle vaadata selle administreerimise reeglid. Aga siis jõudis kätte majanduskriis, mis koondas paljud Euroopa Komisjoni pingutused vaid ühele eesmärgile – Euroopa majanduse kriisist välja toomisele.</span></p>
<p class="MsoNormal"><span lang="ET">Niisiis on EGFist üsna kiiresti saamas hoopis meede majanduskriisiga võitlemiseks. Fondi ümberkujudamise määruse eelnõu kohaselt tõstetakse EL kaasfinantseerimist 50-lt protsendilt 75-le ja lihtsustatakse muid tingimusi. Muuhulgas kaob ajutiselt otsene seos globaliseerumisest tingitud töökohtade kaotamisega ning aktiveerumise piirmäär langeb 500-le kaotatud töökohale.</span></p>
<p class="MsoNormal"><span lang="ET">Praegu arutatakse eelnõud EL Nõukogu töögruppides ning varsti ka Euroopa Parlamendi töö- ja sotsiaalkomisjonis. Kindlasti oleks Eesti huvides arutada rakendumise piirmäära vähendamis veelgi.</span></p>
<p class="MsoNormal"><span lang="ET">EGF ja Sotsiaalfondi kasutamine on üks suurepärane võimalus meie kasvavas tööpuuduses kasvõi natuke leevendust pakkuda. Eurostati andmetel on Eesti üks kiiremini kasvava tööpuudusega riike Euroopa Liidus. Tööpuudus on 2008. aastal kasvanud 4,7 protsendilt 9 protsendini! Eesti ning teiste väikeste liikmesriikide ülesanne ning ka Euroopa Parlamendi saadikute ülesanne on määruse arutelul saavutada võimalikult soodsad tingimused väikeriike silmas pidades, sh fondi aktiveerimise piirmäära vähendamise.</span></p>
<p class="MsoNormal"><span lang="ET">Majandus- ja kommunikatsiooniministeeriumi ametnikud on võtnud endale tänuväärse ülesande kommenteerida struktuurfondidega seotud küsimusi uues blogis <a href="http://toetustasku.blogspot.com">http://toetustasku.blogspot.com</a>. Kuigi see ei puuduta arvatavasti otseselt MKM haldusala, ehk oskaksid nad kommenteerida EGFi otstarbekust Eesti tingimustes aga ka Sotsiaafondi võimalusi majandussurutises ettevõtjate ja töötajate aitamiseks.</span></p>
<p class="MsoNormal"><span lang="ET">EGFist saab lisaks infot <a href="http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/08/792&#38;format=HTML&#38;aged=0&#38;language=EN&#38;guiLanguage=en">siit</a>.</span></p>
<p class="MsoNormal"><span lang="EN-GB"> </span></p>
<p><!--EndFragment--></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[儕瑱｜EGF 抗老美膚淡斑原因]]></title>
<link>http://justin00008888.wordpress.com/2008/10/30/%e5%84%95%e7%91%b1-angastar%ef%bd%9cegf-%e6%8a%97%e8%80%81%e7%be%8e%e8%86%9a%e6%b7%a1%e6%96%91%e5%8e%9f%e5%9b%a0/</link>
<pubDate>Wed, 29 Oct 2008 19:18:00 +0000</pubDate>
<dc:creator>justin00008888</dc:creator>
<guid>http://justin00008888.wordpress.com/2008/10/30/%e5%84%95%e7%91%b1-angastar%ef%bd%9cegf-%e6%8a%97%e8%80%81%e7%be%8e%e8%86%9a%e6%b7%a1%e6%96%91%e5%8e%9f%e5%9b%a0/</guid>
<description><![CDATA[【最火熱的抗老除皺純天然植物性 EGF 生長因子】 以最難生長癒合的糖尿病傷口及燒燙傷的研究做基礎 儕陞生技 再生技術 重症糖尿病足傷口癒合 眾所皆知，糖尿病傷口是全世界公認最難癒合的傷口， 糖尿病患]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><h3>【最火熱的抗老除皺純天然植物性 <a href="http://www.shanpayfun.com/?tag=egf"><strong>EGF</strong></a> 生長因子】</h3>
<p><strong><span style="color:#ff0000;">以最難生長癒合的糖尿病傷口及燒燙傷的研究做基礎</span></strong></p>
<p><a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80"><strong>儕陞生技</strong></a> 再生技術 重症糖尿病足傷口癒合</p>
<p><span style="font-size:16pt;"><strong><span style="color:#669900;">眾</span></strong></span>所皆知，糖尿病傷口是全世界公認最難癒合的傷口，</p>
<p>糖尿病患者的小傷口，</p>
<p>有時候得花很多時間心力來照顧,，才有辦法癒合，</p>
<p>重症的糖尿病傷口，目前因無法治療，</p>
<p>因此經常引發感染壞死發黑 ，導致必須截肢， 稍有不慎容易引發敗血症死亡。<!--more--></p>
<p>可貴的是， <a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80"><strong>儕陞生技</strong></a> 所治癒的～</p>
<p>是一位68歲，有20年糖尿病的患者(50年菸齡並有冠狀動脈疾病(CAD)及慢性腎衰竭(CRF)病史，是最嚴重的糖尿病傷口～</p>
<p>經過一次截肢，之後還是因為末梢循環依舊沒有改善，</p>
<p>足部傷口再次烏黑壞死潰爛。</p>
<p>在醫護人員細心照護下，使用<strong> <a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80">儕陞生技</a></strong> 產品，以全球最強的細胞正常再生能力，加上獨有促進新陳代謝，讓血液循環正常了，使傷口癒合，</p>
<p>皮膚保持潤紅有血色，後續追蹤觀察也不再壞死，</p>
<p>擁有這種能力，才是真正全球最強的細胞健康再生的濟世商品。</p>
<p><img src="http://www.angastar.com/img_src/epaper/cellactive09.jpg" alt="全球最強的糖尿病傷口再生能力" width="500" height="200" /></p>
<blockquote><p><span style="color:#008080;">male 68y/o</span></p>
<p><span style="color:#008080;">DM for 20 years</span></p>
<p><span style="color:#008080;">Smoking for 50 years</span></p>
<p><span style="color:#008080;">History of CAD and CRF</span></p>
<p><span style="color:#008080;">Left foot-the 3rd toe post amputation</span></p>
<p><span style="color:#008080;">Severe gangrene change before treatment</span></p>
</blockquote>
<p>經過多項科學驗證，得知 <a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80"><strong>儕陞生技</strong></a> 的天然植物萃取液</p>
<p>擁有全球最強的 <a href="http://www.shanpayfun.com/?tag=%e7%b4%b0%e8%83%9e%e5%86%8d%e7%94%9f%e5%9b%a0%e5%ad%90"><strong>細胞再生因子</strong></a> ，</p>
<p>更可貴的是，完全不含藥物成分，可食性的特質，</p>
<p>加上安全性的科學試驗，對於人體細胞DNA是完整安全的特性</p>
<p><a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80"><strong>儕陞生技</strong></a> 公司將這項醫學發明專利命名為 <a href="http://www.shanpayfun.com/?tag=charsire"><strong>CHARSIRE</strong></a> 天然 <a href="http://www.shanpayfun.com/?tag=egf"><strong>EGF</strong></a> (生長因子)細胞再生能力夠強，才能真正達到抗老、除皺、美白、淡斑</p>
<p>在實驗室中大家很容易找到有 <a href="http://www.shanpayfun.com/?tag=%e7%b4%b0%e8%83%9e%e5%86%8d%e7%94%9f"><strong>細胞再生</strong></a> 功能的產品，</p>
<p>但是因為細胞再生能力不足 ，</p>
<p>所以沒有產品研究歷史和科學文獻，能像 <a href="http://www.shanpayfun.com/?tag=%e5%84%95%e9%99%9e%e7%94%9f%e6%8a%80"><strong>儕陞生技</strong></a> 有 <strong><span style="color:#ff0000;"><a href="http://www.shanpayfun.com/?p=189">深二度真皮層和全皮層傷口的完整新生報告</a></span></strong>，</p>
<p>更沒有人有辦法，使用嚴重糖尿病傷口能癒合的再生產品，來作為保養品</p>
<p>所以 <a href="http://www.shanpayfun.com/?tag=charsire"><strong>CHARSIRE</strong></a> 天然 <a href="http://www.shanpayfun.com/?tag=egf"><strong>EGF</strong></a> 堪稱是最強的保養聖品！</p>
<blockquote><p>1 ．促進細胞新陳代謝活性</p>
<p>2 ．促進細胞正常的增殖活性（也就是細胞的新生作用)</p>
<p>3 ．細胞 DNA 不變性，長期的塗抹，沒有細胞毒性反應</p>
</blockquote>
<p>更多經驗請見 <a href="http://www.shanpayfun.com/?cat=62"><strong>產品體驗</strong></a></p>
<p><a href="http://www.shanpayfun.com/wp-content/uploads/2008/10/spot.jpg"><img class="alignleft size-full wp-image-186" src="http://www.shanpayfun.com/wp-content/uploads/2008/10/spot.jpg" alt="" width="500" height="190" /></a></p>
<p><img src="http://www.angastar.com/img_src/epaper/spot01.jpg" alt="" width="500" height="220" /></p>
<blockquote><p>文章引用自 <a href="http://www.qoohi.com/"><strong>儕瑱</strong></a> 官網，如需引用敬請告知，謝謝。</p>
</blockquote>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[WO/2008/124161]]></title>
<link>http://kinasepro.wordpress.com/2008/10/22/wo2008124161/</link>
<pubDate>Wed, 22 Oct 2008 05:09:22 +0000</pubDate>
<dc:creator>kinasepro</dc:creator>
<guid>http://kinasepro.wordpress.com/2008/10/22/wo2008124161/</guid>
<description><![CDATA[Exel&#8217;s got Pi3K-a in combination: Reminds one of the XL-147 combo study. So thats XL-647 ?  I ]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://www.wipo.int/pctdb/en/wo.jsp?WO=2008124161">Exel&#8217;s got Pi3K-a in combination</a>: Reminds one of the <a href="http://ir.exelixis.com/phoenix.zhtml?c=120923&#38;p=irol-newsArticle&#38;ID=1215480&#38;highlight=">XL-147</a> <a href="http://www.clinicaltrials.gov/ct2/show/NCT00704392">combo study</a>.</p>
<p style="text-align:center;"><a href="http://kinasepro.wordpress.com/files/2008/10/xl2.jpg"><img class="aligncenter size-full wp-image-676" title="xl2" src="http://kinasepro.wordpress.com/files/2008/10/xl2.jpg" alt="COC1=CC2=C(NC3=CC=C(Cl)C(Cl)=C3F)N=CN=C2C=C1OCC(C4)C[C@]5([H])[C@@]4([H])CN(C)C5" width="500" height="374" /></a></p>
<p style="text-align:center;"><strong>So thats </strong><a href="http://www.exelixis.com/pipeline_xl647.shtml"><strong>XL-647</strong></a> ?  I hadn&#8217;t heard.</p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Phase II nimotuzumab data supports continued development]]></title>
<link>http://kinasecentral.wordpress.com/2008/08/05/phase-ii-nimotuzumab-data-supports-continued-development/</link>
<pubDate>Tue, 05 Aug 2008 15:24:24 +0000</pubDate>
<dc:creator>crimsoncanary</dc:creator>
<guid>http://kinasecentral.wordpress.com/2008/08/05/phase-ii-nimotuzumab-data-supports-continued-development/</guid>
<description><![CDATA[YM Biosciences have released Phase II data that show its EFGR antibody nimotuzumab to be effective i]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://www.ymbiosciences.com/presspop.cfm?newsID=7562">YM Biosciences have released Phase II data that show its EFGR antibody nimotuzumab to be effective in patients with irinotecan–refractory, metastatic colorectal cancer.</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[YM Biosciences EGFR MAb nimotuzumab safe in Phase I]]></title>
<link>http://kinasecentral.wordpress.com/2008/07/22/ym-biosciences-egfr-mab-nimotuzumab-safe-in-phase-i/</link>
<pubDate>Tue, 22 Jul 2008 14:31:29 +0000</pubDate>
<dc:creator>crimsoncanary</dc:creator>
<guid>http://kinasecentral.wordpress.com/2008/07/22/ym-biosciences-egfr-mab-nimotuzumab-safe-in-phase-i/</guid>
<description><![CDATA[Data to be presented at the AACR Centennial Conference on Translational Cancer Medicine today will d]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://www.ymbiosciences.com/presspop.cfm?newsID=7558">Data to be presented at the AACR Centennial Conference on Translational Cancer Medicine today will detail YM Biosciences EGFR MAb nimotuzumab&#8217;s favorable side-effect profile. Data from an ongoing phase II study in colorectal cancer  has confirmed a low level of interaction between nimotuzumab and normal tissue with less than a quarter of the patients exhibiting skin toxicity. </a></p>
<p><a href="http://www.ymbiosciences.com/downloads/AACR_Translational_Med.pdf">Link to Poster</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Genmab initiate Phase I/II trial of zalutumumab (HuMax-EGFr) in colorectal cancer]]></title>
<link>http://kinasecentral.wordpress.com/2008/06/03/genmab-initiate-phase-iii-trial-of-zalutumumab-humax-egfr-in-colorectal-cancer/</link>
<pubDate>Tue, 03 Jun 2008 13:08:46 +0000</pubDate>
<dc:creator>crimsoncanary</dc:creator>
<guid>http://kinasecentral.wordpress.com/2008/06/03/genmab-initiate-phase-iii-trial-of-zalutumumab-humax-egfr-in-colorectal-cancer/</guid>
<description><![CDATA[Genmab have initiated a Phase I/II trial of zalutumumab (HuMax-EGFr) in colorectal cancer. The drug ]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p class="normal"><a href="http://www.genmab.com/PressCentre/RecentNewsReleases/25GenmabInitiatesZalutumumabCombinationStudyinColorectalCancer/Language/English.aspx">Genmab have initiated a Phase I/II trial of zalutumumab   (HuMax-EGFr) in colorectal cancer. The drug will be administered in combination with irinotecan</a></p>
<p class="normal">
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Phase I data on YM BioSciences EGF MAb nimotuzumab for NSCLC]]></title>
<link>http://kinasecentral.wordpress.com/2008/06/02/phase-i-data-on-ym-biosciences-egf-mab-nimotuzumab-for-nsclc/</link>
<pubDate>Mon, 02 Jun 2008 13:52:13 +0000</pubDate>
<dc:creator>crimsoncanary</dc:creator>
<guid>http://kinasecentral.wordpress.com/2008/06/02/phase-i-data-on-ym-biosciences-egf-mab-nimotuzumab-for-nsclc/</guid>
<description><![CDATA[Phase I data presented at ASCO show YM BioSciences EGF MAb nimotuzumab to exhibit efficacy in the tr]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://www.ymbiosciences.com/presspop.cfm?newsID=5532">Phase I data presented at ASCO show YM BioSciences EGF MAb nimotuzumab to exhibit efficacy in the treatment&#60; of non-small cell lung cancer  (NSCLC). Median survival obtained was 60 weeks</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Phase III data of Vectibix/FOLFOX confirms safety and efficacy]]></title>
<link>http://kinasecentral.wordpress.com/2008/06/01/phase-iii-data-of-vectibixfolfox-confirms-safety-and-efficacy/</link>
<pubDate>Sun, 01 Jun 2008 18:28:50 +0000</pubDate>
<dc:creator>crimsoncanary</dc:creator>
<guid>http://kinasecentral.wordpress.com/2008/06/01/phase-iii-data-of-vectibixfolfox-confirms-safety-and-efficacy/</guid>
<description><![CDATA[Data presented at ASCO show Vectibix (panitumumab) in combination with FOLFOX is safe and shows effi]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://www.amgen.com/media/media_pr_detail.jsp?year=2008&#38;releaseID=1160943">Data presented at ASCO show Vectibix (panitumumab) in combination with FOLFOX is safe and shows efficacy in metastatic colorectal cancer</a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing]]></title>
<link>http://coffeeandsci.wordpress.com/2008/04/06/paracrine-factors-of-mesenchymal-stem-cells-recruit-macrophages-and-endothelial-lineage-cells-and-enhance-wound-healing/</link>
<pubDate>Sun, 06 Apr 2008 11:03:53 +0000</pubDate>
<dc:creator>Oldcola</dc:creator>
<guid>http://coffeeandsci.wordpress.com/2008/04/06/paracrine-factors-of-mesenchymal-stem-cells-recruit-macrophages-and-endothelial-lineage-cells-and-enhance-wound-healing/</guid>
<description><![CDATA[Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and En]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p><a href="http://feeds.feedburner.com/~r/plosone/PLoSONE/~3/262557848/info%3Adoi%2F10.1371%2Fjournal.pone.0001886">Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing</a>: &#8221;
<p>by Liwen Chen, Edward E. Tredget, Philip Y. G. Wu, Yaojiong Wu</p>
<p>Bone marrow derived mesenchymal stem cells (BM-MSCs) have been shown to enhance wound healing; however, the mechanisms involved are barely understood. In this study, we examined paracrine factors released by BM-MSCs and their effects on the cells participating in wound healing compared to those released by dermal fibroblasts. Analyses of BM-MSCs with Real-Time PCR and of BM-MSC-conditioned medium by antibody-based protein array and ELISA indicated that BM-MSCs secreted distinctively different cytokines and chemokines, such as greater amounts of VEGF-α, IGF-1, EGF, keratinocyte growth factor, angiopoietin-1, stromal derived factor-1, macrophage inflammatory protein-1alpha and beta and erythropoietin, compared to dermal fibroblasts. These molecules are known to be important in normal wound healing. BM-MSC-conditioned medium significantly enhanced migration of macrophages, keratinocytes and endothelial cells and proliferation of keratinocytes and endothelial cells compared to fibroblast-conditioned medium. Moreover, in a mouse model of excisional wound healing, where concentrated BM-MSC-conditioned medium was applied, accelerated wound healing occurred compared to administration of pre-conditioned or fibroblast-conditioned medium. Analysis of cell suspensions derived from the wound by FACS showed that wounds treated with BM-MSC-conditioned medium had increased proportions of CD4/80-postive macrophages and Flk-1-, CD34- or c-kit-positive endothelial (progenitor) cells compared to wounds treated with pre-conditioned medium or fibroblast-conditioned medium. Consistent with the above findings, immunohistochemical analysis of wound sections showed that wounds treated with BM-MSC-conditioned medium had increased abundance of macrophages. Our results suggest that factors released by BM-MSCs recruit macrophages and endothelial lineage cells into the wound thus enhancing wound healing.</p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[リバーサライザー]]></title>
<link>http://deceivingalexio.wordpress.com/2008/01/27/%e3%83%aa%e3%83%90%e3%83%bc%e3%82%b5%e3%83%a9%e3%82%a4%e3%82%b6%e3%83%bc/</link>
<pubDate>Sun, 27 Jan 2008 00:10:44 +0000</pubDate>
<dc:creator>deceivingalexio</dc:creator>
<guid>http://deceivingalexio.wordpress.com/2008/01/27/%e3%83%aa%e3%83%90%e3%83%bc%e3%82%b5%e3%83%a9%e3%82%a4%e3%82%b6%e3%83%bc/</guid>
<description><![CDATA[リバーサライザー 販売価格￥3,990 ●Wノーベル賞成分でシミ問題にピリオドを！強力アイテム先行発売！●「フラーレン」と「EGF」の強力タッグで、トラブルの進行をストップ＆リバース●ビタミンCの12]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><table style="width:468px;height:268px;font-family:'ＭＳ Ｐゴシック','Osaka－等幅';background-image:url('http://www.moshimo.com/images/clbg0_2_2.gif');background-repeat:no-repeat;font-size:12px;line-height:18px;" border="0" cellpadding="0" cellspacing="0">
<tr>
<td style="width:175px;vertical-align:top;">
<div style="width:154px;height:154px;background-image:url('http://www.moshimo.com/images/cl_frame0_2.gif');float:right;margin-top:30px;"><a href="https://www.moshimo.com/article/205370/26707"><img src="http://www.moshimo.com/item_image/4571268020049/1/r.jpg" style="border:0 none;margin:2px;" alt="リバーサライザー" height="150" width="150" /></a></div>
</td>
<td rowspan="2" style="text-align:left;vertical-align:top;padding:20px 0 0 5px;">
<p style="font-size:18px;font-weight:900;line-height:21px;margin:6px 0;"><a href="https://www.moshimo.com/article/205370/26707">リバーサライザー</a></p>
<p style="font-size:12px;color:#222222;margin:7px 0;"><span style="font-size:14px;font-weight:900;color:#ff1a00;">販売価格￥3,990</span></p>
<p style="text-align:left;color:#222222;margin:5px 20px 0 5px;">●Wノーベル賞成分でシミ問題にピリオドを！強力アイテム先行発売！●「フラーレン」と「EGF」の強力タッグで、トラブルの進行をストップ＆リバース●ビタミンCの125倍、やけど治療の再生に…名だたる成分だから期待して◎！●バシャバシャ使える大容量。本気でシミをなん…</p>
</td>
</tr>
<tr>
<td style="text-align:center;vertical-align:top;"><a href="http://www.moshimo.com/item_image/4571268020049/1/l.jpg" target="_blank"><img src="http://www.moshimo.com/images/cl_bigimg0_2.gif" alt="拡大画像を見る" style="border:0 none;margin-top:5px;" height="23" width="116" /></a></td>
</tr>
<tr>
<td colspan="2" style="text-align:right;"><a href="https://www.moshimo.com/article/205370/26707"><img src="http://www.moshimo.com/images/cl_btn_detailed0_2.gif" alt="商品詳細ページへ" style="border:0 none;margin:10px 3px 17px 0;" height="23" width="140" /></a><a href="https://www.moshimo.com/?action_cart_add&#38;sid=205370&#38;bid=-26707"><img src="http://www.moshimo.com/images/cl_btn_cart0_2.gif" alt="カートページへ" style="border:0 none;margin:10px 20px 17px 0;" height="23" width="140" /></a></td>
</tr>
</table>
<p>大容量！Ｗノーベル賞成分でシミ抜き！？リバーサライザー<br />
<strong>●Wノーベル賞成分でシミ問題にピリオドを！強力アイテム先行発売！<br />
●「フラーレン」と「EGF」の強力タッグで、トラブルの進行をストップ＆リバース<br />
●ビタミンCの125倍、やけど治療の再生に…名だたる成分だから期待して◎！<br />
●バシャバシャ使える大容量。本気でシミをなんとかしたい人に！<br />
</strong></p>
<blockquote><p>「なんだか肌が明るい…？」</p></blockquote>
<p>数々の商品サンプルを試していた開発者が、ある成分の即効性に気づいたことから開発がスタート！シミ撲滅に向け、採算度外視で最高の成分と最高の処方で作っちゃったのが「リバーサライザー」なんです！</p>
<p>そのある成分とは、ノーベル賞受賞のきっかけとなった「フラーレン」。シミを還元漂白するといわれ、最高値時は金の10倍以上もの価格！シミの元凶を抑える抗酸化パワーはビタミンCの125倍、メラニンが作られるのをストップ＆黒色のメラニンを大きく減少！今でさえ商品価格5000円を下回るなんてめったにないの！なのにフラーレン以外にもノーベル賞成分「ＥＧＦ」まで配合。これもヤケド治療など皮膚再生分野で活躍していた成分だから、Ｗノーベル賞成分だけでもウン万円！？ダブルの超実力派成分で、シミの悩みに短期間で結果を出してくれそう！</p>
<blockquote><p>■早くも口コミヒットの予感！？モニター結果は100％が「満足」！</p></blockquote>
<p>いずれも高級成分だけにメーカーさんは価格面で苦労したらしいけど、「肌への効果を考えて、しっかり配合しました」と言うだけあって結果はホンモノ！利益度外視の「本当の実感」にこだわった結果が数字に現れているんです。<br />
しかも、バシャバシャ使える大容量！今まで何を使っても「効かない。。」なんて方にこそ、是非お薦めします！</p>
<blockquote><p>■肌細胞をリバース！</p></blockquote>
<p>他にも、医療現場で使用されてきた人工皮膚成分「リピジュア」、2007年の注目成分「AC-11」も配合。使った翌朝に肌のハリ、透明感を実感していきます。大容量だから、毎日の化粧水として、ローションパックとしてバシャバシャ使えば、1本使いきる頃には「シミがどこにあるのかわからない！」なんて嬉しい悲鳴がでちゃうはず！たっぷり使って目指せ白肌！</p>
<table style="width:468px;height:90px;font-family:'ＭＳ Ｐゴシック','Osaka－等幅';background-image:url('http://www.moshimo.com/images/clbg1_2_2.gif');background-repeat:no-repeat;font-size:12px;line-height:14px;" border="0" cellpadding="0" cellspacing="0">
<tr>
<td rowspan="2" style="text-align:center;vertical-align:middle;width:91px;">
<div style="width:82px;height:82px;background-image:url('http://www.moshimo.com/images/cl_frame1_2.gif');float:right;"><a href="https://www.moshimo.com/article/205370/26707"><img style="border:0 none;margin:1px;" alt="リバーサライザー" /></a></div>
</td>
<td style="text-align:left;padding:0 5px;">
<p style="font-size:16px;font-weight:900;margin:2px 0;"><a href="https://www.moshimo.com/article/205370/26707">リバーサライザー</a></p>
<p style="font-size:12px;color:#222222;margin:3px 0;"><span style="font-size:13px;font-weight:900;color:#ff1a00;">販売価格￥3,990</span></p>
<p style="text-align:left;color:#222222;margin:0 20px 0 0;">●Wノーベル賞成分でシミ問題にピリオドを！強力アイテム先行発売！●「フラーレン」と「EGF」の強力タッグで、ト…</p>
</td>
</tr>
<tr>
<td style="text-align:right;"><a href="https://www.moshimo.com/article/205370/26707"><img src="https://www.moshimo.com/images/cl_btn_detailed1_2.gif" alt="商品詳細ページへ" style="border:0 none;margin:0 5px 3px 0;" height="17" width="101" /></a><a href="https://www.moshimo.com/?action_cart_add&#38;sid=205370&#38;bid=-26707"><img src="http://www.moshimo.com/images/cl_btn_cart1_2.gif" alt="カートページへ" style="border:0 none;margin:0 15px 3px 0;" height="17" width="101" /></a></td>
</tr>
</table>
<p><a href="http://www.moshimo.com/bargain/diet/205370"><img src="http://www.moshimo.com/images/bargain/diet/468-60.jpg" alt="絶対�レイになりたいなら！ - ダイエット通販" style="border:0 none;" height="60" width="468" /></a></p>
</div>]]></content:encoded>
</item>
<item>
<title><![CDATA[PDB Update]]></title>
<link>http://kinasepro.wordpress.com/2007/12/05/pdb-update-34/</link>
<pubDate>Thu, 06 Dec 2007 03:48:24 +0000</pubDate>
<dc:creator>kinasepro</dc:creator>
<guid>http://kinasepro.wordpress.com/2007/12/05/pdb-update-34/</guid>
<description><![CDATA[Berkeley&#8217;s got a Nature 2007, 450, 741 on a peptide that inhibits EGF  and the PDB&#8217;s rel]]></description>
<content:encoded><![CDATA[<div class='snap_preview'><p>Berkeley&#8217;s got a <a href="http://dx.doi.org/10.1038/nature05998"><em><span class="se_journal">Nature</span> </em><strong>2007, 						</strong><span class="se_journal"><em>450</em><strong>, </strong>741</span></a><span class="se_journal"> on a peptide that inhibits EGF  </span><span class="doi"><abbr title="Digital Object Identifier"></abbr></span></p>
<p><span class="se_pagetitle">and the PDB&#8217;s released yesterday: <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=2RFD">2RFD</a> 3.6 </span><span class="se_pagetitle">Å, </span><span class="se_pagetitle"><a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=2RF9">2RF9</a> 3.5 </span><span class="se_pagetitle">Å, </span><a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=2RFE"><span class="se_pagetitle">2RFE</span></a> 2.9 <span class="se_pagetitle">Å</span></p>
<p>To understand what they&#8217;re talking about I had to read the earlier piece in <a href="http://www.cell.com/content/article/abstract?uid=PIIS0092867406005848">Cell</a>.   You could probably just skip it because the <a href="http://dx.doi.org/10.1038/nsmb1207-1120">Monkey Wrench</a> breaks it down for you.</p>
</div>]]></content:encoded>
</item>

</channel>
</rss>
